Thrombosis in cardiovascular medicine: a review of pathophysiology, mechanisms of drug action, and the "alphabet" of established and emerging therapies.

John McCarthy, Jocelyn Szeto

Research output: Contribution to journalReview articlepeer-review

Abstract

Thrombosis is a physiologic hemostatic response to vascular injury. Thrombus generation has evolved as a complex event involving multiphasic biologic inputs and regulation. Pathologic thrombosis in cardiovascular medicine afflicts millions of U.S. citizens per year, exacting a death total in the hundreds of thousands of people. These morbid events are particularly common in the settings of trauma, major surgery, and high-risk medical patients both inside and outside of the hospital. The frequency of all of these risks increases as our population grows and ages. The discussion that follows sketches the roots of our understanding of pathologic thrombosis through a clinical case example, a highlight of the historically key concepts involved, identification of the phasic inputs into thrombus formation and regulation, and a listing of the therapeutics and agents used in treating the thrombosis "epidemic".

Original languageEnglish (US)
Pages (from-to)2-5
Number of pages4
JournalMethodist DeBakey cardiovascular journal
Volume7
Issue number4
DOIs
StatePublished - 2011

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Thrombosis in cardiovascular medicine: a review of pathophysiology, mechanisms of drug action, and the "alphabet" of established and emerging therapies.'. Together they form a unique fingerprint.

Cite this